Table 3.
Characteristics of patients in the proof-of-concept implementation
| UNAFIED patients | Non-UNAFIED patients | All | |
|---|---|---|---|
| No. | 7916 | 14356 | 22272 |
| Race, no. (%) | |||
| Black or African American | 4129 (52.16%) | 6065 (42.25%) | 10194 (45.77%) |
| White | 3009 (38.01%) | 5189 (36.15%) | 8198 (36.81%) |
| Unknown | 451 (5.70%) | 2114 (14.73%) | 2565 (11.52%) |
| More than one race | 155 (1.96%) | 530 (3.69%) | 685 (3.08%) |
| Native Hawaiian or other Pacific Islander | 45 (0.57%) | 202 (1.41%) | 247 (1.11%) |
| Asian | 109 (1.38%) | 217 (1.51%) | 326 (1.46%) |
| American Indian or Alaska Native | 18 (0.23%) | 39 (0.27%) | 57 (0.26%) |
| Ethnicity, no. (%) | |||
| Not Hispanic, Latino/a, or Spanish origin | 7171 (90.59%) | 10913 (76.02%) | 18084 (81.20%) |
| Hispanic or Latino | 595 (7.52%) | 2982 (20.77%) | 3577 (16.06%) |
| Unknown | 150 (1.89%) | 461 (3.21%) | 611 (2.74%) |
| Age, no. (%), years | |||
| 40–44 | 117 (1.48%) | 3222 (22.44%) | 3339 (14.99%) |
| 45–54 | 445 (5.62%) | 5968 (41.57%) | 6413 (28.79%) |
| 55–64 | 2981 (37.66%) | 4203 (29.28%) | 7184 (32.26%) |
| 65–74 | 2815 (35.56%) | 750 (5.22%) | 3565 (16.01%) |
| 75–84 | 1175 (14.84%) | 152 (1.06%) | 1327 (5.96%) |
| 85+ | 383 (4.84%) | 61 (0.42%) | 444 (1.99%) |
| Age, mean (SD), years | 66.46 (9.82) | 51.99 (8.53) | 57.14 (11.37) |
| Sex, no. (%) | |||
| Female | 3930 (49.65%) | 9113 (63.48%) | 13043 (58.56%) |
| Male | 3986 (50.35%) | 5243 (36.52%) | 9229 (41.44%) |
| CHA2DS2-VASc, mean (SD) | 2.557 (1.83) | 1.213 (1.40) | 1.691 (1.69) |